Join the Machine Learning in Medical Imaging Consortium (MaLMIC) for an opportunity to network
Machine learning in Liquid Biopsy
Friday, June 17, 2022
3:30 to 5:30 p.m. ET
Alex Wyatt will give a general introduction to liquid biopsy. This will be followed by Eric Zhao talking about his research work using liquid biopsy in head and neck cancer, and Nick Cheng talking about his research work using liquid biopsy for early detection of high-risk breast cancer. The presentations will be followed by questions and answers about the talks, and discussion focused on lessons learned, opportunities to collaborate and sharing of resources.
Interested in joining? Please contact us.
Machine Learning in Liquid Biopsy
Friday, June 17th, 2022
3:30 to 5:30 p.m. ET
Alex Wyatt will give a general introduction to liquid biopsy. This will be followed by Eric Zhao talking about his research work using liquid biopsy in head and neck cancer, and Nick Cheng talking about his research work using liquid biopsy for early detection of high-risk breast cancer. The presentations will be followed by questions and answers about the talks, and discussion focused on lessons learned, opportunities to collaborate and sharing of resources.
Interested in joining? Please contact us.
Introduction to liquid biopsy and the clinical utility of ctDNA in advanced cancers
Alexander Wyatt , PhD
Assistant Professor, University of British Columbia
Talk summary: Alex will give an overview of the liquid biopsy field in cancer, focusing on circulating tumor DNA (ctDNA). He will draw on some examples from my own research in prostate cancer, where ctDNA is emerging as a new biomarker to monitor treatment response, improve life expectancy predictions, and predict response to anti-cancer therapies.
Monitoring radiotherapy response using liquid biopsy and imaging biomarkers in head and neck cancer
Eric Y. Zhao, MD, PhD
Postdoctoral Fellow and Resident Physician, Princess Margaret Hospital and DKFZ German Cancer Research Center